PHARMACEUTICAL COMPOSITION CONTAINING TRIAZINE DERIVATIVE

The present invention provides a pharmaceutical composition comprising a compound exhibiting coronavirus proliferation inhibitory activity.A pharmaceutical composition comprising a compound represented by the formula: wherein Y is N; R1 is substituted or unsubstituted aromatic heterocyclyl; R2 is su...

Full description

Saved in:
Bibliographic Details
Main Authors TOBA Shinsuke, SAWA Hirofumi, KASAMATSU Koji, FUKAO Keita, UEMURA Kentaro, TACHIBANA Yuki, KURODA Takayuki, NAKAHARA Kenji, ANDO Shigeru, SASAKI Michihito, NOBORI Haruaki, MARUYAMA Yuki, YAMATSU Yukiko, UEHARA Shota, TAODA Yoshiyuki, UNOH Yuto
Format Patent
LanguageEnglish
French
German
Published 07.08.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a pharmaceutical composition comprising a compound exhibiting coronavirus proliferation inhibitory activity.A pharmaceutical composition comprising a compound represented by the formula: wherein Y is N; R1 is substituted or unsubstituted aromatic heterocyclyl; R2 is substituted or unsubstituted 6-membered aromatic carbocyclyl; R3 is substituted or unsubstituted aromatic heterocyclyl; -X- is -NH-; m is 0 or 1; R5a is a hydrogen atom; R5b is a hydrogen atom; n is 1; R4a is a hydrogen atom; and R4b is a hydrogen atom, or a pharmaceutically acceptable salt thereof.
Bibliography:Application Number: EP20220876159